[HTML][HTML] Untargeted UPLC-MS-based metabolomics analysis reveals the metabolic profile of intrahepatic cholangiocarcinoma process and the intervention effect of …
X Chen, H Liu, L Shen, D Li, B Zhang, X Ji… - Pharmacological …, 2022 - Elsevier
Intrahepatic cholangiocarcinoma (ICC) is the second most common malignant liver tumor
after hepatocellular carcinoma (HCC). It poses a significant risk to human health as it is …
after hepatocellular carcinoma (HCC). It poses a significant risk to human health as it is …